

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | aminoglycoside antibiotic metabolic process (GO:0030647) | 7.56534901 |
| 2 | negative regulation of macroautophagy (GO:0016242) | 5.38981307 |
| 3 | detection of molecule of bacterial origin (GO:0032490) | 5.12581368 |
| 4 | exogenous drug catabolic process (GO:0042738) | 4.90845804 |
| 5 | drug catabolic process (GO:0042737) | 4.71091263 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.55683122 |
| 7 | viral mRNA export from host cell nucleus (GO:0046784) | 4.52137651 |
| 8 | behavioral response to nicotine (GO:0035095) | 4.45848998 |
| 9 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.34335910 |
| 10 | oxaloacetate metabolic process (GO:0006107) | 4.19708640 |
| 11 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 4.08510899 |
| 12 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 4.08510899 |
| 13 | L-serine metabolic process (GO:0006563) | 4.03555694 |
| 14 | NADH metabolic process (GO:0006734) | 3.89733839 |
| 15 | cysteine metabolic process (GO:0006534) | 3.84729239 |
| 16 | high-density lipoprotein particle remodeling (GO:0034375) | 3.83806773 |
| 17 | response to pheromone (GO:0019236) | 3.78495740 |
| 18 | kynurenine metabolic process (GO:0070189) | 3.78394887 |
| 19 | indole-containing compound catabolic process (GO:0042436) | 3.75894724 |
| 20 | indolalkylamine catabolic process (GO:0046218) | 3.75894724 |
| 21 | tryptophan catabolic process (GO:0006569) | 3.75894724 |
| 22 | ribosomal small subunit biogenesis (GO:0042274) | 3.73397590 |
| 23 | detection of external biotic stimulus (GO:0098581) | 3.71093415 |
| 24 | maturation of SSU-rRNA (GO:0030490) | 3.70956834 |
| 25 | cellular anion homeostasis (GO:0030002) | 3.69451853 |
| 26 | phosphate ion homeostasis (GO:0055062) | 3.65092786 |
| 27 | trivalent inorganic anion homeostasis (GO:0072506) | 3.65092786 |
| 28 | lysine catabolic process (GO:0006554) | 3.60599907 |
| 29 | lysine metabolic process (GO:0006553) | 3.60599907 |
| 30 | opioid receptor signaling pathway (GO:0038003) | 3.54507910 |
| 31 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.52450423 |
| 32 | ribosome biogenesis (GO:0042254) | 3.52175947 |
| 33 | aromatic amino acid family catabolic process (GO:0009074) | 3.51018632 |
| 34 | mitochondrial RNA metabolic process (GO:0000959) | 3.49026352 |
| 35 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.48467479 |
| 36 | positive regulation of glycolytic process (GO:0045821) | 3.46651845 |
| 37 | chaperone-mediated protein transport (GO:0072321) | 3.45073957 |
| 38 | reverse cholesterol transport (GO:0043691) | 3.40603379 |
| 39 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.38889846 |
| 40 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.37291017 |
| 41 | protein maturation by protein folding (GO:0022417) | 3.37109664 |
| 42 | phospholipid efflux (GO:0033700) | 3.36850052 |
| 43 | pseudouridine synthesis (GO:0001522) | 3.32406802 |
| 44 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.28737804 |
| 45 | sulfur amino acid catabolic process (GO:0000098) | 3.28670843 |
| 46 | serine family amino acid biosynthetic process (GO:0009070) | 3.27782992 |
| 47 | negative regulation of fibrinolysis (GO:0051918) | 3.26519598 |
| 48 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.26277512 |
| 49 | L-phenylalanine metabolic process (GO:0006558) | 3.26277512 |
| 50 | regulation of mitochondrial translation (GO:0070129) | 3.25437165 |
| 51 | regulation of cholesterol esterification (GO:0010872) | 3.24253417 |
| 52 | tryptophan metabolic process (GO:0006568) | 3.23268720 |
| 53 | folic acid transport (GO:0015884) | 3.23178386 |
| 54 | urea cycle (GO:0000050) | 3.21307457 |
| 55 | urea metabolic process (GO:0019627) | 3.21307457 |
| 56 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.19566205 |
| 57 | auditory receptor cell stereocilium organization (GO:0060088) | 3.17175643 |
| 58 | negative regulation of meiosis (GO:0045835) | 3.15634369 |
| 59 | proline biosynthetic process (GO:0006561) | 3.15100136 |
| 60 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.12696957 |
| 61 | L-phenylalanine catabolic process (GO:0006559) | 3.12696957 |
| 62 | succinate metabolic process (GO:0006105) | 3.12595070 |
| 63 | alpha-linolenic acid metabolic process (GO:0036109) | 3.12501430 |
| 64 | positive regulation of synapse maturation (GO:0090129) | 3.10827037 |
| 65 | fructose metabolic process (GO:0006000) | 3.10649262 |
| 66 | detection of biotic stimulus (GO:0009595) | 3.09784480 |
| 67 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.06781160 |
| 68 | GDP-mannose metabolic process (GO:0019673) | 3.05353884 |
| 69 | coenzyme catabolic process (GO:0009109) | 3.04455459 |
| 70 | sulfate transmembrane transport (GO:1902358) | 3.03602319 |
| 71 | regulation of triglyceride catabolic process (GO:0010896) | 3.01683892 |
| 72 | tricarboxylic acid cycle (GO:0006099) | 3.01477615 |
| 73 | arginine metabolic process (GO:0006525) | 3.01289970 |
| 74 | post-embryonic morphogenesis (GO:0009886) | 3.01078069 |
| 75 | negative regulation of sterol transport (GO:0032372) | 2.99713590 |
| 76 | negative regulation of cholesterol transport (GO:0032375) | 2.99713590 |
| 77 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.99520818 |
| 78 | regulation of translation in response to stress (GO:0043555) | 2.99267970 |
| 79 | cellular glucuronidation (GO:0052695) | 2.98535740 |
| 80 | NAD metabolic process (GO:0019674) | 2.97343120 |
| 81 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.95971320 |
| 82 | regulation of cholesterol homeostasis (GO:2000188) | 2.94924638 |
| 83 | intestinal cholesterol absorption (GO:0030299) | 2.94406159 |
| 84 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.90502588 |
| 85 | plasma lipoprotein particle remodeling (GO:0034369) | 2.89680256 |
| 86 | protein-lipid complex remodeling (GO:0034368) | 2.89680256 |
| 87 | macromolecular complex remodeling (GO:0034367) | 2.89680256 |
| 88 | histone arginine methylation (GO:0034969) | 2.87648976 |
| 89 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.87418791 |
| 90 | regulation of protein activation cascade (GO:2000257) | 2.86728036 |
| 91 | protein-cofactor linkage (GO:0018065) | 2.85685400 |
| 92 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.84020137 |
| 93 | cholesterol efflux (GO:0033344) | 2.83669446 |
| 94 | homocysteine metabolic process (GO:0050667) | 2.82244021 |
| 95 | sphingosine metabolic process (GO:0006670) | 2.81766161 |
| 96 | tRNA processing (GO:0008033) | 2.80809205 |
| 97 | positive regulation of neurotransmitter transport (GO:0051590) | 2.79729311 |
| 98 | regulation of bile acid biosynthetic process (GO:0070857) | 2.79411098 |
| 99 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.79364561 |
| 100 | plasma lipoprotein particle clearance (GO:0034381) | 2.78457870 |
| 101 | vocalization behavior (GO:0071625) | 2.76947575 |
| 102 | protein localization to microtubule (GO:0035372) | 2.76560825 |
| 103 | microtubule severing (GO:0051013) | 2.75989476 |
| 104 | regulation of translational fidelity (GO:0006450) | 2.75096431 |
| 105 | tRNA metabolic process (GO:0006399) | 2.74784949 |
| 106 | COPI coating of Golgi vesicle (GO:0048205) | 2.73444544 |
| 107 | Golgi transport vesicle coating (GO:0048200) | 2.73444544 |
| 108 | arginine catabolic process (GO:0006527) | 2.72555226 |
| 109 | alpha-amino acid catabolic process (GO:1901606) | 2.72040285 |
| 110 | nitrogen cycle metabolic process (GO:0071941) | 2.71086745 |
| 111 | cellular component biogenesis (GO:0044085) | 2.70705878 |
| 112 | aspartate family amino acid catabolic process (GO:0009068) | 2.69599642 |
| 113 | tRNA aminoacylation for protein translation (GO:0006418) | 2.67861297 |
| 114 | negative regulation of fatty acid metabolic process (GO:0045922) | 2.67761549 |
| 115 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.67748397 |
| 116 | nucleoside transmembrane transport (GO:1901642) | 2.67401302 |
| 117 | prostate gland growth (GO:0060736) | 2.67060938 |
| 118 | folic acid metabolic process (GO:0046655) | 2.66894560 |
| 119 | regulation of complement activation (GO:0030449) | 2.66046494 |
| 120 | hexose biosynthetic process (GO:0019319) | 2.65232655 |
| 121 | gluconeogenesis (GO:0006094) | 2.65216666 |
| 122 | serine family amino acid catabolic process (GO:0009071) | 2.64621304 |
| 123 | 2-oxoglutarate metabolic process (GO:0006103) | 2.64173642 |
| 124 | L-ascorbic acid metabolic process (GO:0019852) | 2.64071362 |
| 125 | microtubule nucleation (GO:0007020) | 2.63908130 |
| 126 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.63659098 |
| 127 | amino-acid betaine metabolic process (GO:0006577) | 2.62990502 |
| 128 | rRNA processing (GO:0006364) | 2.62693932 |
| 129 | regulation of fibrinolysis (GO:0051917) | 2.61964809 |
| 130 | lateral ventricle development (GO:0021670) | 2.61395818 |
| 131 | cellular modified amino acid catabolic process (GO:0042219) | 2.61341215 |
| 132 | maturation of 5.8S rRNA (GO:0000460) | 2.60513067 |
| 133 | fat-soluble vitamin catabolic process (GO:0042363) | 2.59584894 |
| 134 | vitamin catabolic process (GO:0009111) | 2.59584894 |
| 135 | regulation of plasminogen activation (GO:0010755) | 2.59395395 |
| 136 | zinc ion transmembrane transport (GO:0071577) | 2.59283568 |
| 137 | amino acid activation (GO:0043038) | 2.59024592 |
| 138 | tRNA aminoacylation (GO:0043039) | 2.59024592 |
| 139 | bicarbonate transport (GO:0015701) | 2.58993915 |
| 140 | alanine transport (GO:0032328) | 2.58520861 |
| 141 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.58227205 |
| 142 | tRNA methylation (GO:0030488) | 2.57802593 |
| 143 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.55977576 |
| 144 | negative regulation of response to nutrient levels (GO:0032108) | 2.55645647 |
| 145 | negative regulation of response to extracellular stimulus (GO:0032105) | 2.55645647 |
| 146 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.55143419 |
| 147 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.54101155 |
| 148 | serine family amino acid metabolic process (GO:0009069) | 2.53221582 |
| 149 | ncRNA processing (GO:0034470) | 2.49995901 |
| 150 | DNA strand elongation (GO:0022616) | 2.49631345 |
| 151 | pteridine-containing compound metabolic process (GO:0042558) | 2.46079933 |
| 152 | DNA strand renaturation (GO:0000733) | 2.44826261 |
| 153 | tetrahydrofolate metabolic process (GO:0046653) | 2.44714063 |
| 154 | rRNA metabolic process (GO:0016072) | 2.43391618 |
| 155 | negative regulation of macrophage differentiation (GO:0045650) | 2.42571152 |
| 156 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.42035855 |
| 157 | tRNA modification (GO:0006400) | 2.39327577 |
| 158 | protein retention in ER lumen (GO:0006621) | 2.37760600 |
| 159 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.34866782 |
| 160 | basic amino acid transport (GO:0015802) | 2.34360323 |
| 161 | folic acid-containing compound metabolic process (GO:0006760) | 2.33913087 |
| 162 | rRNA modification (GO:0000154) | 2.32587342 |
| 163 | 7-methylguanosine mRNA capping (GO:0006370) | 2.32314960 |
| 164 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.31331413 |
| 165 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.29829696 |
| 166 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.29829696 |
| 167 | rRNA methylation (GO:0031167) | 2.29584652 |
| 168 | nucleotide transmembrane transport (GO:1901679) | 2.28873197 |
| 169 | nucleoside transport (GO:0015858) | 2.28597202 |
| 170 | transcription from mitochondrial promoter (GO:0006390) | 2.28103387 |
| 171 | peptidyl-arginine N-methylation (GO:0035246) | 2.26370781 |
| 172 | peptidyl-arginine methylation (GO:0018216) | 2.26370781 |
| 173 | paraxial mesoderm development (GO:0048339) | 2.25684656 |
| 174 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.25243040 |
| 175 | rRNA transcription (GO:0009303) | 2.24101805 |
| 176 | heterochromatin organization (GO:0070828) | 2.23876173 |
| 177 | ribosomal large subunit biogenesis (GO:0042273) | 2.23288961 |
| 178 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.22816522 |
| 179 | sulfur amino acid biosynthetic process (GO:0000097) | 2.22610228 |
| 180 | ncRNA metabolic process (GO:0034660) | 2.22021530 |
| 181 | isoprenoid biosynthetic process (GO:0008299) | 2.21416561 |
| 182 | amyloid precursor protein catabolic process (GO:0042987) | 2.20735294 |
| 183 | RNA capping (GO:0036260) | 2.20338626 |
| 184 | 7-methylguanosine RNA capping (GO:0009452) | 2.20338626 |
| 185 | cytokinetic process (GO:0032506) | 2.19968418 |
| 186 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.18306501 |
| 187 | galactose catabolic process (GO:0019388) | 2.18010229 |
| 188 | RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502) | 2.17089985 |
| 189 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.16911490 |
| 190 | proteasome assembly (GO:0043248) | 2.16462620 |
| 191 | mitotic chromosome condensation (GO:0007076) | 2.16110512 |
| 192 | daunorubicin metabolic process (GO:0044597) | 12.0638423 |
| 193 | polyketide metabolic process (GO:0030638) | 12.0638423 |
| 194 | doxorubicin metabolic process (GO:0044598) | 12.0638423 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.28849096 |
| 2 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 5.14853554 |
| 3 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 4.98713791 |
| 4 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.92890868 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.75165460 |
| 6 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.16883223 |
| 7 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.84440222 |
| 8 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.54844173 |
| 9 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.41069754 |
| 10 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.40650074 |
| 11 | RXR_22108803_ChIP-Seq_LS180_Human | 3.37680278 |
| 12 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.19523071 |
| 13 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.05049655 |
| 14 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.98705547 |
| 15 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.97118079 |
| 16 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.85011493 |
| 17 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.79852237 |
| 18 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.72987827 |
| 19 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.67969629 |
| 20 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.62296044 |
| 21 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.62034792 |
| 22 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.41596748 |
| 23 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.40764380 |
| 24 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.34718995 |
| 25 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.33119367 |
| 26 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.31021229 |
| 27 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.29911815 |
| 28 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.23488537 |
| 29 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.18392303 |
| 30 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.17914964 |
| 31 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.15287106 |
| 32 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.13976605 |
| 33 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.06875052 |
| 34 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.06387979 |
| 35 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.97010285 |
| 36 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.95549426 |
| 37 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.90721186 |
| 38 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.90518063 |
| 39 | * ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.90074115 |
| 40 | VDR_22108803_ChIP-Seq_LS180_Human | 1.86227900 |
| 41 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.84291142 |
| 42 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.82207449 |
| 43 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.79050926 |
| 44 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.77905504 |
| 45 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.71331123 |
| 46 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.67726439 |
| 47 | * NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.67523782 |
| 48 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.66970944 |
| 49 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.66445098 |
| 50 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.65116335 |
| 51 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.64856077 |
| 52 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.63873056 |
| 53 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 1.61825502 |
| 54 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.60228951 |
| 55 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.59515574 |
| 56 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.59201151 |
| 57 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.59059466 |
| 58 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.58123146 |
| 59 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.55860180 |
| 60 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.51218709 |
| 61 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.46572151 |
| 62 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.45507566 |
| 63 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.40744481 |
| 64 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.39857303 |
| 65 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.38960207 |
| 66 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.38843828 |
| 67 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.37495343 |
| 68 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.34113951 |
| 69 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.34086347 |
| 70 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.34020870 |
| 71 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.33861243 |
| 72 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.33302738 |
| 73 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.32317208 |
| 74 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.32253051 |
| 75 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.31883607 |
| 76 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.31501038 |
| 77 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.30462053 |
| 78 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.29578932 |
| 79 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.29215205 |
| 80 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.29081609 |
| 81 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.28068668 |
| 82 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.27510708 |
| 83 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.26600659 |
| 84 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.26467557 |
| 85 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.25791124 |
| 86 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.25432712 |
| 87 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.25319522 |
| 88 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.24917816 |
| 89 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.24810881 |
| 90 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.24498886 |
| 91 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.24452563 |
| 92 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.23983768 |
| 93 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.23734192 |
| 94 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.22996861 |
| 95 | AR_25329375_ChIP-Seq_VCAP_Human | 1.22313519 |
| 96 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.21603217 |
| 97 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.20567671 |
| 98 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.20269125 |
| 99 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.20076473 |
| 100 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.20057740 |
| 101 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.19890740 |
| 102 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.19804525 |
| 103 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.19547174 |
| 104 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.18850338 |
| 105 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.18052443 |
| 106 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.17199569 |
| 107 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.12938584 |
| 108 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.11796146 |
| 109 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.11644359 |
| 110 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.11469102 |
| 111 | ATF3_27146783_Chip-Seq_COLON_Human | 1.11126389 |
| 112 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.06022048 |
| 113 | * NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.05304767 |
| 114 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.05212950 |
| 115 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.05004716 |
| 116 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.02965528 |
| 117 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.02802493 |
| 118 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.02633196 |
| 119 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.01827395 |
| 120 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.01535788 |
| 121 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.01286554 |
| 122 | * TP53_22573176_ChIP-Seq_HFKS_Human | 1.01016977 |
| 123 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.00915230 |
| 124 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.00328492 |
| 125 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00323568 |
| 126 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.00145371 |
| 127 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.99549137 |
| 128 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.99423189 |
| 129 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.98521969 |
| 130 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.96735830 |
| 131 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.96617432 |
| 132 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.96246726 |
| 133 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.96217494 |
| 134 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.96123901 |
| 135 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.95989848 |
| 136 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.95979860 |
| 137 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.95816457 |
| 138 | * E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.95745865 |
| 139 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.95691537 |
| 140 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.95539088 |
| 141 | P300_19829295_ChIP-Seq_ESCs_Human | 0.95285234 |
| 142 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.93042903 |
| 143 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.92680967 |
| 144 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.92671094 |
| 145 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92322982 |
| 146 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.91542500 |
| 147 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.89639846 |
| 148 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.89628499 |
| 149 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.89417555 |
| 150 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.86645276 |
| 151 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.86416875 |
| 152 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.83812524 |
| 153 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.83550090 |
| 154 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.83005706 |
| 155 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.81982592 |
| 156 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.81009507 |
| 157 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.80924271 |
| 158 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.79808744 |
| 159 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.79634847 |
| 160 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.77799630 |
| 161 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.76957719 |
| 162 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.76811051 |
| 163 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.76544051 |
| 164 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.76352361 |
| 165 | JUN_21703547_ChIP-Seq_K562_Human | 0.76215661 |
| 166 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.76189837 |
| 167 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.75994334 |
| 168 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.75690959 |
| 169 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.75628088 |
| 170 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.74792258 |
| 171 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.74256973 |
| 172 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.74107928 |
| 173 | NCOR_22424771_ChIP-Seq_293T_Human | 0.73112769 |
| 174 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.72420430 |
| 175 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.71513756 |
| 176 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.71359520 |
| 177 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.71359520 |
| 178 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.71271980 |
| 179 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.71207491 |
| 180 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.70894267 |
| 181 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.69583909 |
| 182 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.68729103 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.30177580 |
| 2 | MP0008004_abnormal_stomach_pH | 4.33247334 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 4.31403320 |
| 4 | MP0010030_abnormal_orbit_morphology | 3.96978374 |
| 5 | MP0002254_reproductive_system_inflammat | 3.83999785 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 3.81685534 |
| 7 | MP0005365_abnormal_bile_salt | 3.67501256 |
| 8 | MP0003941_abnormal_skin_development | 3.61641406 |
| 9 | MP0003705_abnormal_hypodermis_morpholog | 3.50637886 |
| 10 | MP0003878_abnormal_ear_physiology | 3.21743439 |
| 11 | MP0005377_hearing/vestibular/ear_phenot | 3.21743439 |
| 12 | MP0010329_abnormal_lipoprotein_level | 3.20691382 |
| 13 | MP0005257_abnormal_intraocular_pressure | 2.97095606 |
| 14 | MP0009697_abnormal_copulation | 2.80326742 |
| 15 | MP0000566_synostosis | 2.74080347 |
| 16 | MP0003646_muscle_fatigue | 2.63227542 |
| 17 | MP0003693_abnormal_embryo_hatching | 2.61325414 |
| 18 | MP0003879_abnormal_hair_cell | 2.59170084 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 2.48318133 |
| 20 | MP0005408_hypopigmentation | 2.45537212 |
| 21 | MP0003252_abnormal_bile_duct | 2.34873758 |
| 22 | MP0003890_abnormal_embryonic-extraembry | 2.34599692 |
| 23 | MP0001346_abnormal_lacrimal_gland | 2.30570062 |
| 24 | MP0005248_abnormal_Harderian_gland | 2.28452609 |
| 25 | MP0003950_abnormal_plasma_membrane | 2.26172506 |
| 26 | MP0009840_abnormal_foam_cell | 2.22082106 |
| 27 | MP0002796_impaired_skin_barrier | 2.09176958 |
| 28 | MP0004957_abnormal_blastocyst_morpholog | 2.04738395 |
| 29 | MP0003111_abnormal_nucleus_morphology | 1.99952354 |
| 30 | MP0008058_abnormal_DNA_repair | 1.98517208 |
| 31 | MP0008875_abnormal_xenobiotic_pharmacok | 1.91736937 |
| 32 | MP0005058_abnormal_lysosome_morphology | 1.87156421 |
| 33 | MP0001881_abnormal_mammary_gland | 1.85162487 |
| 34 | MP0001666_abnormal_nutrient_absorption | 1.82629987 |
| 35 | MP0008438_abnormal_cutaneous_collagen | 1.82119630 |
| 36 | MP0005670_abnormal_white_adipose | 1.80275944 |
| 37 | MP0003806_abnormal_nucleotide_metabolis | 1.80085512 |
| 38 | MP0009379_abnormal_foot_pigmentation | 1.79715796 |
| 39 | MP0005645_abnormal_hypothalamus_physiol | 1.71661357 |
| 40 | MP0003942_abnormal_urinary_system | 1.70853370 |
| 41 | MP0008932_abnormal_embryonic_tissue | 1.69333750 |
| 42 | MP0002697_abnormal_eye_size | 1.67721153 |
| 43 | MP0003186_abnormal_redox_activity | 1.66505740 |
| 44 | MP0005083_abnormal_biliary_tract | 1.60760591 |
| 45 | MP0002138_abnormal_hepatobiliary_system | 1.60012632 |
| 46 | MP0005332_abnormal_amino_acid | 1.59252265 |
| 47 | MP0000678_abnormal_parathyroid_gland | 1.59136318 |
| 48 | MP0002938_white_spotting | 1.57981920 |
| 49 | MP0000003_abnormal_adipose_tissue | 1.56631672 |
| 50 | MP0001293_anophthalmia | 1.53173904 |
| 51 | MP0001764_abnormal_homeostasis | 1.50930206 |
| 52 | MP0003718_maternal_effect | 1.50452722 |
| 53 | MP0009384_cardiac_valve_regurgitation | 1.48138115 |
| 54 | MP0004019_abnormal_vitamin_homeostasis | 1.43646836 |
| 55 | MP0001542_abnormal_bone_strength | 1.42404966 |
| 56 | MP0003566_abnormal_cell_adhesion | 1.42160972 |
| 57 | MP0000609_abnormal_liver_physiology | 1.40592819 |
| 58 | MP0010234_abnormal_vibrissa_follicle | 1.38194304 |
| 59 | MP0001730_embryonic_growth_arrest | 1.37860203 |
| 60 | MP0005423_abnormal_somatic_nervous | 1.36724487 |
| 61 | MP0005451_abnormal_body_composition | 1.34849188 |
| 62 | MP0000749_muscle_degeneration | 1.33813535 |
| 63 | MP0004133_heterotaxia | 1.32043313 |
| 64 | MP0004233_abnormal_muscle_weight | 1.31435705 |
| 65 | MP0010386_abnormal_urinary_bladder | 1.30671152 |
| 66 | MP0002132_abnormal_respiratory_system | 1.29554980 |
| 67 | MP0000750_abnormal_muscle_regeneration | 1.26490881 |
| 68 | MP0000427_abnormal_hair_cycle | 1.25369968 |
| 69 | MP0010094_abnormal_chromosome_stability | 1.24942663 |
| 70 | MP0005197_abnormal_uvea_morphology | 1.19131570 |
| 71 | MP0000534_abnormal_ureter_morphology | 1.17469039 |
| 72 | MP0001348_abnormal_lacrimal_gland | 1.17227023 |
| 73 | MP0001664_abnormal_digestion | 1.15193205 |
| 74 | MP0005275_abnormal_skin_tensile | 1.12743185 |
| 75 | MP0002118_abnormal_lipid_homeostasis | 1.12533050 |
| 76 | MP0002084_abnormal_developmental_patter | 1.10758303 |
| 77 | MP0000013_abnormal_adipose_tissue | 1.10300404 |
| 78 | MP0000358_abnormal_cell_content/ | 1.10115900 |
| 79 | MP0004858_abnormal_nervous_system | 1.09860417 |
| 80 | MP0003183_abnormal_peptide_metabolism | 1.08733043 |
| 81 | MP0005501_abnormal_skin_physiology | 1.06386029 |
| 82 | MP0002085_abnormal_embryonic_tissue | 1.06077716 |
| 83 | MP0002837_dystrophic_cardiac_calcinosis | 1.05218366 |
| 84 | MP0003077_abnormal_cell_cycle | 1.04859172 |
| 85 | MP0001529_abnormal_vocalization | 1.03388770 |
| 86 | MP0002876_abnormal_thyroid_physiology | 1.03296523 |
| 87 | MP0003279_aneurysm | 1.03122049 |
| 88 | MP0003937_abnormal_limbs/digits/tail_de | 1.02693586 |
| 89 | MP0002638_abnormal_pupillary_reflex | 1.02346207 |
| 90 | MP0000627_abnormal_mammary_gland | 1.02008742 |
| 91 | MP0003283_abnormal_digestive_organ | 1.01838928 |
| 92 | MP0004859_abnormal_synaptic_plasticity | 1.00987205 |
| 93 | MP0003786_premature_aging | 1.00897347 |
| 94 | MP0002822_catalepsy | 1.00314265 |
| 95 | MP0000762_abnormal_tongue_morphology | 1.00285537 |
| 96 | MP0000462_abnormal_digestive_system | 0.99970966 |
| 97 | MP0005503_abnormal_tendon_morphology | 0.98613423 |
| 98 | MP0002092_abnormal_eye_morphology | 0.98253785 |
| 99 | MP0001672_abnormal_embryogenesis/_devel | 0.94927223 |
| 100 | MP0005380_embryogenesis_phenotype | 0.94927223 |
| 101 | MP0000681_abnormal_thyroid_gland | 0.92384316 |
| 102 | MP0005319_abnormal_enzyme/_coenzyme | 0.92151505 |
| 103 | MP0003984_embryonic_growth_retardation | 0.90858020 |
| 104 | MP0001697_abnormal_embryo_size | 0.89705604 |
| 105 | MP0008007_abnormal_cellular_replicative | 0.89022417 |
| 106 | MP0002080_prenatal_lethality | 0.87450230 |
| 107 | MP0002088_abnormal_embryonic_growth/wei | 0.86753209 |
| 108 | MP0001944_abnormal_pancreas_morphology | 0.86326149 |
| 109 | MP0005220_abnormal_exocrine_pancreas | 0.85718282 |
| 110 | MP0000604_amyloidosis | 0.85328011 |
| 111 | MP0002075_abnormal_coat/hair_pigmentati | 0.84971413 |
| 112 | MP0003385_abnormal_body_wall | 0.83842957 |
| 113 | MP0003755_abnormal_palate_morphology | 0.83778218 |
| 114 | MP0003045_fibrosis | 0.83679333 |
| 115 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.83331957 |
| 116 | MP0001186_pigmentation_phenotype | 0.82560692 |
| 117 | MP0009672_abnormal_birth_weight | 0.82551049 |
| 118 | MP0005551_abnormal_eye_electrophysiolog | 0.81947571 |
| 119 | MP0001286_abnormal_eye_development | 0.81939796 |
| 120 | MP0009046_muscle_twitch | 0.80976166 |
| 121 | MP0003453_abnormal_keratinocyte_physiol | 0.77209723 |
| 122 | MP0009780_abnormal_chondrocyte_physiolo | 0.76994711 |
| 123 | MP0005395_other_phenotype | 0.76683985 |
| 124 | MP0002160_abnormal_reproductive_system | 0.76648537 |
| 125 | MP0003868_abnormal_feces_composition | 0.75070189 |
| 126 | MP0001756_abnormal_urination | 0.74026996 |
| 127 | MP0001849_ear_inflammation | 0.73526196 |
| 128 | MP0000579_abnormal_nail_morphology | 0.71924002 |
| 129 | MP0003119_abnormal_digestive_system | 0.71201580 |
| 130 | MP0002078_abnormal_glucose_homeostasis | 0.70502475 |
| 131 | MP0005193_abnormal_anterior_eye | 0.69586698 |
| 132 | MP0006054_spinal_hemorrhage | 0.69581980 |
| 133 | MP0009643_abnormal_urine_homeostasis | 0.69146853 |
| 134 | MP0009053_abnormal_anal_canal | 0.68781798 |
| 135 | MP0004043_abnormal_pH_regulation | 0.68114305 |
| 136 | MP0000371_diluted_coat_color | 0.67749476 |
| 137 | MP0002736_abnormal_nociception_after | 0.67616494 |
| 138 | MP0002233_abnormal_nose_morphology | 0.67166225 |
| 139 | MP0005330_cardiomyopathy | 0.66296758 |
| 140 | MP0004147_increased_porphyrin_level | 0.66112594 |
| 141 | MP0006035_abnormal_mitochondrial_morpho | 0.64954654 |
| 142 | MP0002877_abnormal_melanocyte_morpholog | 0.64849377 |
| 143 | MP0001661_extended_life_span | 0.64313196 |
| 144 | MP0002896_abnormal_bone_mineralization | 0.63158277 |
| 145 | MP0003329_amyloid_beta_deposits | 0.61249454 |
| 146 | MP0005647_abnormal_sex_gland | 0.61154777 |
| 147 | MP0002269_muscular_atrophy | 0.61121824 |
| 148 | MP0005379_endocrine/exocrine_gland_phen | 0.59877173 |
| 149 | MP0000858_altered_metastatic_potential | 0.58567175 |
| 150 | MP0005084_abnormal_gallbladder_morpholo | 0.57782488 |
| 151 | MP0001177_atelectasis | 0.56228242 |
| 152 | MP0009745_abnormal_behavioral_response | 0.55475837 |
| 153 | MP0003123_paternal_imprinting | 0.55165541 |
| 154 | MP0005636_abnormal_mineral_homeostasis | 0.55018869 |
| 155 | MP0004084_abnormal_cardiac_muscle | 0.53535388 |
| 156 | MP0002069_abnormal_eating/drinking_beha | 0.53122903 |
| 157 | MP0005646_abnormal_pituitary_gland | 0.52143384 |
| 158 | MP0004264_abnormal_extraembryonic_tissu | 0.51593538 |
| 159 | MP0002089_abnormal_postnatal_growth/wei | 0.51284018 |
| 160 | MP0002971_abnormal_brown_adipose | 0.50388209 |
| 161 | MP0004272_abnormal_basement_membrane | 0.50109248 |
| 162 | MP0002168_other_aberrant_phenotype | 0.48760091 |
| 163 | MP0002557_abnormal_social/conspecific_i | 0.48260418 |
| 164 | MP0000538_abnormal_urinary_bladder | 0.47060965 |
| 165 | MP0004782_abnormal_surfactant_physiolog | 0.45961449 |
| 166 | MP0003638_abnormal_response/metabolism_ | 0.44839047 |
| 167 | MP0003635_abnormal_synaptic_transmissio | 0.43785812 |
| 168 | MP0001968_abnormal_touch/_nociception | 0.43498172 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Alopecia of scalp (HP:0002293) | 6.13182322 |
| 2 | Bilateral sensorineural hearing impairment (HP:0008619) | 5.45292866 |
| 3 | Parakeratosis (HP:0001036) | 5.31900750 |
| 4 | Unilateral renal agenesis (HP:0000122) | 5.18502716 |
| 5 | Absent eyelashes (HP:0000561) | 5.13773566 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 4.63102013 |
| 7 | Follicular hyperkeratosis (HP:0007502) | 4.26827241 |
| 8 | Abnormality of dental color (HP:0011073) | 4.09698581 |
| 9 | Reticulocytopenia (HP:0001896) | 4.04205120 |
| 10 | Absent eyebrow (HP:0002223) | 4.02755403 |
| 11 | Hypolipoproteinemia (HP:0010981) | 3.81397306 |
| 12 | Xanthomatosis (HP:0000991) | 3.67100411 |
| 13 | Intrahepatic cholestasis (HP:0001406) | 3.66791723 |
| 14 | Recurrent corneal erosions (HP:0000495) | 3.60294939 |
| 15 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.55649972 |
| 16 | Deep venous thrombosis (HP:0002625) | 3.55435039 |
| 17 | Entropion (HP:0000621) | 3.41112147 |
| 18 | Hyperglycinemia (HP:0002154) | 3.38796681 |
| 19 | Cheilitis (HP:0100825) | 3.36807778 |
| 20 | Mitral stenosis (HP:0001718) | 3.36067933 |
| 21 | Hypoalphalipoproteinemia (HP:0003233) | 3.29936905 |
| 22 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.28693091 |
| 23 | Hyperlipoproteinemia (HP:0010980) | 3.27824370 |
| 24 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.16865028 |
| 25 | Erythroderma (HP:0001019) | 3.13730856 |
| 26 | Pigmentary retinal degeneration (HP:0001146) | 3.01705706 |
| 27 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.95968240 |
| 28 | Hyperammonemia (HP:0001987) | 2.89082237 |
| 29 | Abnormal number of erythroid precursors (HP:0012131) | 2.86807343 |
| 30 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.80320981 |
| 31 | Prolonged neonatal jaundice (HP:0006579) | 2.71014697 |
| 32 | Abnormality of DNA repair (HP:0003254) | 2.69819845 |
| 33 | Oligomenorrhea (HP:0000876) | 2.67100752 |
| 34 | Vacuolated lymphocytes (HP:0001922) | 2.66691543 |
| 35 | Abnormality of proline metabolism (HP:0010907) | 2.64958452 |
| 36 | Hydroxyprolinuria (HP:0003080) | 2.64958452 |
| 37 | Abolished electroretinogram (ERG) (HP:0000550) | 2.63052034 |
| 38 | Abnormal gallbladder physiology (HP:0012438) | 2.56897102 |
| 39 | Cholecystitis (HP:0001082) | 2.56897102 |
| 40 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.56012355 |
| 41 | Chronic otitis media (HP:0000389) | 2.55480945 |
| 42 | Conjugated hyperbilirubinemia (HP:0002908) | 2.54879423 |
| 43 | Hyperglycemia (HP:0003074) | 2.53484313 |
| 44 | Poikiloderma (HP:0001029) | 2.53255877 |
| 45 | Abnormality of reticulocytes (HP:0004312) | 2.50928583 |
| 46 | Premature rupture of membranes (HP:0001788) | 2.48488247 |
| 47 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.46376846 |
| 48 | Poor suck (HP:0002033) | 2.45687172 |
| 49 | Urticaria (HP:0001025) | 2.45598309 |
| 50 | Myopathic facies (HP:0002058) | 2.43348426 |
| 51 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.42732482 |
| 52 | Secondary amenorrhea (HP:0000869) | 2.41403339 |
| 53 | Horseshoe kidney (HP:0000085) | 2.41075345 |
| 54 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.40425221 |
| 55 | Abnormality of glycine metabolism (HP:0010895) | 2.40425221 |
| 56 | Tetraparesis (HP:0002273) | 2.36944331 |
| 57 | Squamous cell carcinoma (HP:0002860) | 2.34532231 |
| 58 | Absent hair (HP:0002298) | 2.32912053 |
| 59 | Abnormality of the labia minora (HP:0012880) | 2.31663599 |
| 60 | Vascular calcification (HP:0004934) | 2.31501214 |
| 61 | Delayed CNS myelination (HP:0002188) | 2.30566552 |
| 62 | Back pain (HP:0003418) | 2.30525858 |
| 63 | Prolonged partial thromboplastin time (HP:0003645) | 2.29081967 |
| 64 | Right ventricular cardiomyopathy (HP:0011663) | 2.28553136 |
| 65 | Gout (HP:0001997) | 2.28455396 |
| 66 | Abnormality of the intrinsic pathway (HP:0010989) | 2.27674585 |
| 67 | Abnormality of nucleobase metabolism (HP:0010932) | 2.27598082 |
| 68 | Hyperphosphatemia (HP:0002905) | 2.27304610 |
| 69 | Hyperventilation (HP:0002883) | 2.26684192 |
| 70 | Congenital stationary night blindness (HP:0007642) | 2.25537335 |
| 71 | Cerebral hypomyelination (HP:0006808) | 2.24042682 |
| 72 | Abnormality of subcutaneous fat tissue (HP:0001001) | 2.22636350 |
| 73 | Fat malabsorption (HP:0002630) | 2.21814224 |
| 74 | Palmoplantar hyperkeratosis (HP:0000972) | 2.20887161 |
| 75 | Cardiovascular calcification (HP:0011915) | 2.20543776 |
| 76 | Absent/shortened dynein arms (HP:0200106) | 2.19222316 |
| 77 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.19222316 |
| 78 | Chromsome breakage (HP:0040012) | 2.18613504 |
| 79 | Abnormality of the common coagulation pathway (HP:0010990) | 2.18350548 |
| 80 | Abnormality of purine metabolism (HP:0004352) | 2.18208700 |
| 81 | Abnormality of serum amino acid levels (HP:0003112) | 2.16477506 |
| 82 | Blepharitis (HP:0000498) | 2.16284751 |
| 83 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.16014075 |
| 84 | Abnormality of alanine metabolism (HP:0010916) | 2.16014075 |
| 85 | Hyperalaninemia (HP:0003348) | 2.16014075 |
| 86 | Vertebral arch anomaly (HP:0008438) | 2.14864656 |
| 87 | Abnormality of the umbilical cord (HP:0010881) | 2.14239214 |
| 88 | Abnormal biliary tract physiology (HP:0012439) | 2.13902883 |
| 89 | Bile duct proliferation (HP:0001408) | 2.13902883 |
| 90 | Erythema (HP:0010783) | 2.13401525 |
| 91 | Flat acetabular roof (HP:0003180) | 2.13258509 |
| 92 | CNS hypomyelination (HP:0003429) | 2.11585467 |
| 93 | Hyperglycinuria (HP:0003108) | 2.10242171 |
| 94 | Hypoglycemic seizures (HP:0002173) | 2.08302163 |
| 95 | Progressive muscle weakness (HP:0003323) | 2.07840427 |
| 96 | Premature ovarian failure (HP:0008209) | 2.07237517 |
| 97 | Palmar hyperkeratosis (HP:0010765) | 2.05291065 |
| 98 | Distal lower limb muscle weakness (HP:0009053) | 2.04016524 |
| 99 | Pterygium (HP:0001059) | 2.03862127 |
| 100 | Bifid tongue (HP:0010297) | 2.03783805 |
| 101 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.02626208 |
| 102 | Tubulointerstitial fibrosis (HP:0005576) | 2.01273545 |
| 103 | Curly hair (HP:0002212) | 2.01034831 |
| 104 | Trismus (HP:0000211) | 2.00772536 |
| 105 | Hypoplasia of the pons (HP:0012110) | 2.00233942 |
| 106 | Abnormality of the pons (HP:0007361) | 1.99262188 |
| 107 | Ketosis (HP:0001946) | 1.98885230 |
| 108 | Upper limb muscle weakness (HP:0003484) | 1.98677711 |
| 109 | Increased serum lactate (HP:0002151) | 1.97845655 |
| 110 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.97544468 |
| 111 | Absent epiphyses (HP:0010577) | 1.97544468 |
| 112 | Popliteal pterygium (HP:0009756) | 1.97066038 |
| 113 | Hypercholesterolemia (HP:0003124) | 1.96396412 |
| 114 | Fibular aplasia (HP:0002990) | 1.95623670 |
| 115 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.95357772 |
| 116 | Pendular nystagmus (HP:0012043) | 1.93530864 |
| 117 | Hypoplastic pelvis (HP:0008839) | 1.91126557 |
| 118 | Acute encephalopathy (HP:0006846) | 1.90836892 |
| 119 | Chorioretinal atrophy (HP:0000533) | 1.90758931 |
| 120 | Slender long bone (HP:0003100) | 1.89798983 |
| 121 | Type II lissencephaly (HP:0007260) | 1.88489276 |
| 122 | Reduced antithrombin III activity (HP:0001976) | 1.86370975 |
| 123 | Metabolic acidosis (HP:0001942) | 1.86320091 |
| 124 | Systemic lupus erythematosus (HP:0002725) | 1.85907977 |
| 125 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.85210334 |
| 126 | Delayed gross motor development (HP:0002194) | 1.84849686 |
| 127 | Complement deficiency (HP:0004431) | 1.84355050 |
| 128 | Amniotic constriction ring (HP:0009775) | 1.83474305 |
| 129 | Abnormality of placental membranes (HP:0011409) | 1.83474305 |
| 130 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.82129109 |
| 131 | Ileus (HP:0002595) | 1.80373867 |
| 132 | Global brain atrophy (HP:0002283) | 1.78770625 |
| 133 | Increased CSF lactate (HP:0002490) | 1.78363013 |
| 134 | Reticulocytosis (HP:0001923) | 1.78323907 |
| 135 | Symptomatic seizures (HP:0011145) | 1.77114683 |
| 136 | Postnatal microcephaly (HP:0005484) | 1.76840674 |
| 137 | Tongue fasciculations (HP:0001308) | 1.76486654 |
| 138 | Acute necrotizing encephalopathy (HP:0006965) | 1.76178548 |
| 139 | Spastic diplegia (HP:0001264) | 1.75763168 |
| 140 | Breech presentation (HP:0001623) | 1.74733992 |
| 141 | Epileptic encephalopathy (HP:0200134) | 1.73824657 |
| 142 | Plantar hyperkeratosis (HP:0007556) | 1.73107938 |
| 143 | Long palpebral fissure (HP:0000637) | 1.71740615 |
| 144 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.71675345 |
| 145 | Long toe (HP:0010511) | 1.70744883 |
| 146 | Hyperuricemia (HP:0002149) | 1.70671033 |
| 147 | Increased purine levels (HP:0004368) | 1.70671033 |
| 148 | Cholelithiasis (HP:0001081) | 1.70281302 |
| 149 | Limb-girdle muscle atrophy (HP:0003797) | 1.69746084 |
| 150 | Abnormality of glycolysis (HP:0004366) | 1.69409987 |
| 151 | Increased serum pyruvate (HP:0003542) | 1.69409987 |
| 152 | Proximal tubulopathy (HP:0000114) | 1.69276952 |
| 153 | Athetosis (HP:0002305) | 1.67788128 |
| 154 | Disproportionate short-trunk short stature (HP:0003521) | 1.67082145 |
| 155 | Nonimmune hydrops fetalis (HP:0001790) | 1.66681318 |
| 156 | Adrenal hypoplasia (HP:0000835) | 1.66341782 |
| 157 | Abnormal tarsal ossification (HP:0008369) | 1.65553395 |
| 158 | Personality changes (HP:0000751) | 1.64920303 |
| 159 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.64685784 |
| 160 | Single umbilical artery (HP:0001195) | 1.64685784 |
| 161 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.64685784 |
| 162 | Sensorimotor neuropathy (HP:0007141) | 1.64518730 |
| 163 | Renal duplication (HP:0000075) | 1.64079637 |
| 164 | Cutaneous melanoma (HP:0012056) | 1.63880698 |
| 165 | Abnormal gallbladder morphology (HP:0012437) | 1.63115478 |
| 166 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.62627534 |
| 167 | Achilles tendon contracture (HP:0001771) | 1.62441408 |
| 168 | Overriding aorta (HP:0002623) | 1.61257204 |
| 169 | Myelomeningocele (HP:0002475) | 1.60644723 |
| 170 | Decreased subcutaneous fat (HP:0001002) | 1.59266691 |
| 171 | Absent thumb (HP:0009777) | 1.58904724 |
| 172 | Esophageal varix (HP:0002040) | 1.57429168 |
| 173 | Glossoptosis (HP:0000162) | 1.56534544 |
| 174 | Vertebral compression fractures (HP:0002953) | 1.55604992 |
| 175 | Birth length less than 3rd percentile (HP:0003561) | 1.52754869 |
| 176 | Stridor (HP:0010307) | 1.51917913 |
| 177 | Increased hepatocellular lipid droplets (HP:0006565) | 1.51656210 |
| 178 | Abnormality of the tricuspid valve (HP:0001702) | 1.50942605 |
| 179 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.50702862 |
| 180 | Self-mutilation (HP:0000742) | 1.48582216 |
| 181 | Blindness (HP:0000618) | 1.47437120 |
| 182 | Hand muscle atrophy (HP:0009130) | 1.46592510 |
| 183 | Microglossia (HP:0000171) | 1.42913758 |
| 184 | Abnormality of carpal bone ossification (HP:0006257) | 1.42017353 |
| 185 | Anophthalmia (HP:0000528) | 1.41150649 |
| 186 | Protrusio acetabuli (HP:0003179) | 1.41019007 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA2 | 5.07494328 |
| 2 | SIK1 | 4.62191217 |
| 3 | VRK2 | 4.39547436 |
| 4 | NME2 | 4.24197419 |
| 5 | SIK3 | 4.22074365 |
| 6 | SIK2 | 3.00265913 |
| 7 | IRAK3 | 2.78624992 |
| 8 | RPS6KB2 | 2.40777559 |
| 9 | MARK3 | 2.38231120 |
| 10 | PAK4 | 2.31451520 |
| 11 | MAPKAPK3 | 2.28832168 |
| 12 | LATS1 | 2.27989140 |
| 13 | NEK1 | 2.27707091 |
| 14 | STK16 | 2.17116122 |
| 15 | LATS2 | 2.16494144 |
| 16 | STK38L | 2.15698626 |
| 17 | SMG1 | 2.15484424 |
| 18 | AKT3 | 2.13529337 |
| 19 | EPHA4 | 2.12071330 |
| 20 | TESK2 | 2.08819375 |
| 21 | LIMK1 | 2.06690431 |
| 22 | NME1 | 2.04267031 |
| 23 | BRAF | 2.03609065 |
| 24 | CASK | 1.90367206 |
| 25 | TAOK2 | 1.87245490 |
| 26 | EPHA3 | 1.84814050 |
| 27 | PDK3 | 1.76088780 |
| 28 | PDK4 | 1.76088780 |
| 29 | TSSK6 | 1.72090254 |
| 30 | PLK2 | 1.70003116 |
| 31 | PRPF4B | 1.65316157 |
| 32 | EEF2K | 1.61639529 |
| 33 | MAP3K13 | 1.56392387 |
| 34 | BCKDK | 1.41024736 |
| 35 | ABL2 | 1.40183886 |
| 36 | FRK | 1.38602822 |
| 37 | ARAF | 1.29398255 |
| 38 | PRKCG | 1.29251149 |
| 39 | PTK2 | 1.28743154 |
| 40 | ICK | 1.27831102 |
| 41 | BRSK2 | 1.27312764 |
| 42 | DAPK2 | 1.26065719 |
| 43 | DYRK2 | 1.25665019 |
| 44 | FER | 1.25197881 |
| 45 | EIF2AK1 | 1.24371883 |
| 46 | SRPK1 | 1.22959417 |
| 47 | NEK2 | 1.14772434 |
| 48 | MAP3K11 | 1.11912057 |
| 49 | TYK2 | 1.10042067 |
| 50 | LMTK2 | 1.08593720 |
| 51 | TTK | 1.08278069 |
| 52 | PTK6 | 1.07840921 |
| 53 | PBK | 1.05400595 |
| 54 | PRKG2 | 1.04118017 |
| 55 | MAP3K9 | 1.02917803 |
| 56 | ERN1 | 1.01331462 |
| 57 | BUB1 | 0.99944734 |
| 58 | MUSK | 0.97770256 |
| 59 | BRSK1 | 0.97093593 |
| 60 | AURKA | 0.96745764 |
| 61 | PRKD3 | 0.96342920 |
| 62 | MAP3K5 | 0.96084645 |
| 63 | PLK3 | 0.96077710 |
| 64 | SGK2 | 0.95579163 |
| 65 | PHKG1 | 0.93002392 |
| 66 | PHKG2 | 0.93002392 |
| 67 | PRKCZ | 0.88910537 |
| 68 | ADRBK2 | 0.86959253 |
| 69 | MAP3K12 | 0.84547276 |
| 70 | TESK1 | 0.83587688 |
| 71 | TAF1 | 0.82801395 |
| 72 | MAP2K4 | 0.82056768 |
| 73 | CCNB1 | 0.81214327 |
| 74 | NTRK3 | 0.79076738 |
| 75 | MAP3K14 | 0.79010583 |
| 76 | CDK9 | 0.78661387 |
| 77 | CAMK2G | 0.78448577 |
| 78 | WNK4 | 0.77323713 |
| 79 | PDK2 | 0.76328742 |
| 80 | SCYL2 | 0.75231803 |
| 81 | DYRK3 | 0.75055388 |
| 82 | STK38 | 0.73922231 |
| 83 | ILK | 0.73423346 |
| 84 | KSR2 | 0.70333531 |
| 85 | EIF2AK3 | 0.69030085 |
| 86 | TYRO3 | 0.68280837 |
| 87 | PLK1 | 0.67811913 |
| 88 | MTOR | 0.67401129 |
| 89 | INSRR | 0.65058518 |
| 90 | SGK3 | 0.64707363 |
| 91 | NEK9 | 0.63109128 |
| 92 | PLK4 | 0.62208912 |
| 93 | VRK1 | 0.62037612 |
| 94 | AURKB | 0.61399700 |
| 95 | MAP3K3 | 0.60824394 |
| 96 | MAP2K1 | 0.59989840 |
| 97 | CDK7 | 0.59458571 |
| 98 | PIM2 | 0.58689576 |
| 99 | TRIB3 | 0.58468948 |
| 100 | SGK223 | 0.57687555 |
| 101 | SGK494 | 0.57687555 |
| 102 | PRKCI | 0.57176423 |
| 103 | CAMK2D | 0.56421810 |
| 104 | CLK1 | 0.56209825 |
| 105 | ATR | 0.54489357 |
| 106 | CDK8 | 0.54382424 |
| 107 | MST1R | 0.51323978 |
| 108 | CHEK1 | 0.51267664 |
| 109 | ALK | 0.49939455 |
| 110 | RPS6KA2 | 0.49818148 |
| 111 | MAP3K8 | 0.49019856 |
| 112 | TAOK1 | 0.48146265 |
| 113 | MAPKAPK5 | 0.47874163 |
| 114 | TTN | 0.47833538 |
| 115 | MAP3K7 | 0.45834275 |
| 116 | RIPK1 | 0.44773826 |
| 117 | PRKCE | 0.43847656 |
| 118 | RAF1 | 0.43759613 |
| 119 | CSNK1G1 | 0.42904998 |
| 120 | ERBB4 | 0.42416320 |
| 121 | CHEK2 | 0.40577483 |
| 122 | ADRBK1 | 0.40000946 |
| 123 | CSNK1A1 | 0.39629446 |
| 124 | PAK3 | 0.39179457 |
| 125 | CSNK2A2 | 0.38825844 |
| 126 | AKT2 | 0.38715513 |
| 127 | DAPK3 | 0.38336145 |
| 128 | BRD4 | 0.37609498 |
| 129 | GRK6 | 0.37294276 |
| 130 | TBK1 | 0.36157205 |
| 131 | MAPK11 | 0.36069908 |
| 132 | CSNK1E | 0.35246359 |
| 133 | PRKAA1 | 0.35223061 |
| 134 | MINK1 | 0.34919178 |
| 135 | PRKCH | 0.34903584 |
| 136 | DYRK1B | 0.34841385 |
| 137 | PKN2 | 0.34796073 |
| 138 | CSNK2A1 | 0.34371259 |
| 139 | EIF2AK2 | 0.34342894 |
| 140 | MKNK2 | 0.34063832 |
| 141 | STK3 | 0.31977707 |
| 142 | CDK4 | 0.30462316 |
| 143 | CDK1 | 0.30206722 |
| 144 | NUAK1 | 0.29418835 |
| 145 | DDR2 | 0.29183302 |
| 146 | MAP2K6 | 0.28908938 |
| 147 | DAPK1 | 0.26858712 |
| 148 | MAP3K4 | 0.26812958 |
| 149 | TRPM7 | 0.26653993 |
| 150 | CSNK1D | 0.26251672 |
| 151 | FGFR1 | 0.26240636 |
| 152 | PAK1 | 0.26211744 |
| 153 | RPS6KA4 | 0.23802375 |
| 154 | MAP2K3 | 0.22753146 |
| 155 | EPHB2 | 0.22553893 |
| 156 | SGK1 | 0.22218498 |
| 157 | JAK1 | 0.21643010 |
| 158 | MAPK7 | 0.21234601 |
| 159 | PRKCA | 0.20592283 |
| 160 | CSNK1A1L | 0.20224877 |
| 161 | WNK3 | 0.19269358 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.87782545 |
| 2 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.61291640 |
| 3 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.10951551 |
| 4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.98601162 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.84185005 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.79637365 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.71639063 |
| 8 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.54769624 |
| 9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.15854036 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.12164402 |
| 11 | Ribosome_Homo sapiens_hsa03010 | 2.08874287 |
| 12 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 2.07428531 |
| 13 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.02487006 |
| 14 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.96125402 |
| 15 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.94835325 |
| 16 | DNA replication_Homo sapiens_hsa03030 | 1.94437812 |
| 17 | Carbon metabolism_Homo sapiens_hsa01200 | 1.90204566 |
| 18 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.89912259 |
| 19 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.88359173 |
| 20 | RNA polymerase_Homo sapiens_hsa03020 | 1.81758636 |
| 21 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.80753162 |
| 22 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.77169499 |
| 23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.74631765 |
| 24 | Nicotine addiction_Homo sapiens_hsa05033 | 1.71806934 |
| 25 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.58270172 |
| 26 | Proteasome_Homo sapiens_hsa03050 | 1.57088746 |
| 27 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.54282570 |
| 28 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.51609883 |
| 29 | Mineral absorption_Homo sapiens_hsa04978 | 1.51317672 |
| 30 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.50924251 |
| 31 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.44987689 |
| 32 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.44422418 |
| 33 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.43757266 |
| 34 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.43717206 |
| 35 | RNA transport_Homo sapiens_hsa03013 | 1.43513038 |
| 36 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.43409105 |
| 37 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.42005555 |
| 38 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.41569134 |
| 39 | Base excision repair_Homo sapiens_hsa03410 | 1.40402617 |
| 40 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.38880214 |
| 41 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.37105113 |
| 42 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.36366710 |
| 43 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.35711854 |
| 44 | Mismatch repair_Homo sapiens_hsa03430 | 1.35259887 |
| 45 | Peroxisome_Homo sapiens_hsa04146 | 1.34789055 |
| 46 | Protein export_Homo sapiens_hsa03060 | 1.34417474 |
| 47 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.33776758 |
| 48 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.33538904 |
| 49 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.32859019 |
| 50 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.31861557 |
| 51 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.30792310 |
| 52 | Parkinsons disease_Homo sapiens_hsa05012 | 1.29269567 |
| 53 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.25609634 |
| 54 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.25205195 |
| 55 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.23318149 |
| 56 | Retinol metabolism_Homo sapiens_hsa00830 | 1.21897379 |
| 57 | Huntingtons disease_Homo sapiens_hsa05016 | 1.21242949 |
| 58 | Bile secretion_Homo sapiens_hsa04976 | 1.19823023 |
| 59 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.19680012 |
| 60 | Other glycan degradation_Homo sapiens_hsa00511 | 1.18379977 |
| 61 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.16911268 |
| 62 | Spliceosome_Homo sapiens_hsa03040 | 1.15595960 |
| 63 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.14433924 |
| 64 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.13868257 |
| 65 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.13753766 |
| 66 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.12642576 |
| 67 | Galactose metabolism_Homo sapiens_hsa00052 | 1.10479585 |
| 68 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.09307106 |
| 69 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.07977934 |
| 70 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.07759867 |
| 71 | Basal transcription factors_Homo sapiens_hsa03022 | 1.07548813 |
| 72 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.04271606 |
| 73 | Homologous recombination_Homo sapiens_hsa03440 | 1.04118779 |
| 74 | Alzheimers disease_Homo sapiens_hsa05010 | 0.98713345 |
| 75 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.96788839 |
| 76 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.96459572 |
| 77 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.94803336 |
| 78 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.94621945 |
| 79 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.92414167 |
| 80 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.88868152 |
| 81 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.88302613 |
| 82 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.87101362 |
| 83 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.86325269 |
| 84 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.85567029 |
| 85 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.82926271 |
| 86 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.82757517 |
| 87 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.81031408 |
| 88 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.70307512 |
| 89 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.69994502 |
| 90 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.69240723 |
| 91 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.68929057 |
| 92 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.68217117 |
| 93 | GABAergic synapse_Homo sapiens_hsa04727 | 0.68199991 |
| 94 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.66084396 |
| 95 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.65484086 |
| 96 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.65060180 |
| 97 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.64678556 |
| 98 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.64642448 |
| 99 | Purine metabolism_Homo sapiens_hsa00230 | 0.63111070 |
| 100 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.59000227 |
| 101 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.58339791 |
| 102 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.58183747 |
| 103 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.58183453 |
| 104 | Lysosome_Homo sapiens_hsa04142 | 0.57591304 |
| 105 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.57357967 |
| 106 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.56890147 |
| 107 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.55304308 |
| 108 | Phototransduction_Homo sapiens_hsa04744 | 0.52666842 |
| 109 | Sulfur relay system_Homo sapiens_hsa04122 | 0.50305880 |
| 110 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.45793642 |
| 111 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.45641706 |
| 112 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.45085813 |
| 113 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.44243105 |
| 114 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.43885129 |
| 115 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.41754191 |
| 116 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.41515067 |
| 117 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.39921981 |
| 118 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.38840026 |
| 119 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.38823248 |
| 120 | Cell cycle_Homo sapiens_hsa04110 | 0.38613920 |
| 121 | RNA degradation_Homo sapiens_hsa03018 | 0.38069434 |
| 122 | Bladder cancer_Homo sapiens_hsa05219 | 0.37992286 |
| 123 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.35422217 |
| 124 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.35179155 |
| 125 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.34697301 |
| 126 | Tight junction_Homo sapiens_hsa04530 | 0.33384384 |
| 127 | Metabolic pathways_Homo sapiens_hsa01100 | 0.32823082 |
| 128 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.31650123 |
| 129 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.30759784 |
| 130 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.30075016 |
| 131 | Melanoma_Homo sapiens_hsa05218 | 0.28862706 |
| 132 | Lysine degradation_Homo sapiens_hsa00310 | 0.28458176 |
| 133 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.26415687 |
| 134 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.23872201 |
| 135 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.23365180 |
| 136 | Morphine addiction_Homo sapiens_hsa05032 | 0.23046620 |
| 137 | Long-term potentiation_Homo sapiens_hsa04720 | 0.20744056 |
| 138 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.20120143 |
| 139 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.19383031 |
| 140 | Phagosome_Homo sapiens_hsa04145 | 0.19158232 |
| 141 | Insulin secretion_Homo sapiens_hsa04911 | 0.18224830 |
| 142 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.17969456 |
| 143 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.17190911 |
| 144 | Insulin resistance_Homo sapiens_hsa04931 | 0.16512049 |
| 145 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.14706139 |
| 146 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.14599185 |
| 147 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.14332178 |

